Components of the metabolic syndrome and colorectal cancer risk; a prospective study (Q44649962)

5 December 2017

title

Components of the metabolic syndrome and colorectal cancer risk; a prospective study (English)

1 reference

5 December 2017

1 reference

1 reference

1 reference

6

Hallmans G

1 reference

5 December 2017

7

Kaaks R

1 reference

5 December 2017

Stocks T

1

1 reference

5 December 2017

Lukanova A

2

1 reference

5 December 2017

Johansson M

3

1 reference

5 December 2017

Rinaldi S

4

1 reference

5 December 2017

Palmqvist R

5

1 reference

5 December 2017

Stattin P

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

18 September 2007

1 reference

International Journal of Obesity

5 December 2017

published in

1 reference

5 December 2017

volume

32

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

304-314

1 reference

Overweight, obesity, and cancer risk

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Pathogenesis of NIDDM. A balanced overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Nutrition, insulin, insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Increased blood glucose and insulin, body size, and incident colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

The metabolic syndrome and risk of incident colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Metabolic abnormalities and risk for colorectal cancer in the physicians' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

The metabolic syndrome: a concept hard to define

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Glycosylated haemoglobin: measurement and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Hemoglobin A1c can be analyzed in blood kept frozen at -80 degrees C and is not commonly affected by hemolysis in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Hemoglobin A1c concentrations and risk of colorectal cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Serum adiponectin is not associated with risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Obesity, insulin resistance and diabetes — a worldwide epidemic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Obesity and colon cancer: Does leptin provide a link?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

A prospective study of plasma C-peptide and colorectal cancer risk in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Hypertension and long-term cancer incidence and mortality among Swedish men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

The regulation of insulin‐like growth factor binding protein (IGFBP)‐1 during prolonged fasting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

How to measure insulin secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803713

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803713

1 reference

5 December 2017

1 reference